Holen Sie sich die Stockscreener-App
13.20
6.91%
-0.98
Handel nachbörslich:
13.17
-0.03
-0.23%
Schlusskurs vom Vortag:
$14.18
Offen:
$14.43
24-Stunden-Volumen:
175.75K
Relative Volume:
0.39
Marktkapitalisierung:
$492.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+16.30%
1M Leistung:
+20.99%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$13.15
$14.56
1-Wochen-Bereich:
$11.60
$15.75
52-Wochen-Spanne:
$8.89
$24.36
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Vergleichen Sie BBNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
13.20 | 492.09M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
129.05 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.53 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.11 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.50 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Transcript : Beta Bionics, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 09 - marketscreener.com
Beta Bionics Q1 2025 Earnings: Strong Growth and Optimism - TipRanks
Strong Performance and Growth Potential: Buy Rating for Beta Bionics, Inc. - TipRanks
Earnings call transcript: Beta Bionics Q1 2025 earnings miss estimates - Investing.com Australia
Positive Developments and Strong Financial Performance Drive Buy Rating for Beta Bionics, Inc. - TipRanks
Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 - GlobeNewswire
Beta Bionics Inc (BBNX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... By GuruFocus - Investing.com Canada
Beta Bionics Reports Strong Q1 2025 Results and Raises Guidance - TipRanks
Beta Bionics Q1 2025 slides: raised guidance despite earnings miss - Investing.com
Beta Bionics Q1 2025 slides: raised guidance despite earnings miss By Investing.com - Investing.com South Africa
Beta Bionics Q1 2025 Earnings Call Transcript - MarketBeat
Critical Review: Beta Bionics (NASDAQ:BBNX) and INVO Bioscience (NASDAQ:INVO) - Defense World
Beta Bionics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Highest quarter in years as med-tech raises $8B in Q1 financings - BioWorld MedTech
Beta Bionics to Present at the Bank of America Securities Health Care Conference - The Manila Times
Midday Stock Roundup: FivePoint Rises on Earnings - Orange County Business Journal
Beta Bionics: Slowing Down Or Being Conservative? (NASDAQ:BBNX) - Seeking Alpha
Beta Bionics, Inc. (NASDAQ:BBNX) Receives $24.83 Average Target Price from Analysts - Defense World
beta bionics, inc., Earnings dates - RTTNews
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 - The Manila Times
Beta Bionics, Inc. to Release First Quarter 2025 Financial Results on May 6, 2025 - Nasdaq
Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal
Beta Bionics to Host Investor Event on June 22, 2025 - The Manila Times
CUBE LAUNCHES REGPLATFORM™ INTEL TO TRANSFORM THE MID-MARKET REGULATORY INTELLIGENCE LANDSCAPE IN FINANCIAL SERVICES - The Globe and Mail
Stifel maintains Buy rating on Beta Bionics stock, target at $25 - Investing.com Canada
SCHD ETF News, 4/2/2025 - The Globe and Mail
Beta Bionics, Inc.: Undervalued Growth Opportunity with Strategic Expansion Plans - TipRanks
Beta Bionics shares ‘too cheap’ with estimates going higher, says BofA - TipRanks
Beta Bionics Explodes to $65.1M in Revenue - Orange County Business Journal
Midday Stock Roundup: Rivian Rises - Orange County Business Journal
Newly public Beta Bionics reports sales surge; Dexcom hires CCO - MedTech Dive
Beta Bionics welcomes new board member Gerard Michel By Investing.com - Investing.com Australia
Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa
Beta Bionics appoints new board member from Delcath Systems - Investing.com India
Beta Bionics welcomes new board member Gerard Michel - Investing.com
Beta Bionics Appoints Gerard Michel as Director - TipRanks
Beta Bionics Announces Board Appointment of Gerard Michel - The Manila Times
Stifel maintains Buy on Beta Bionics stock, $25 price target By Investing.com - Investing.com South Africa
Piper Sandler maintains $26 target on Beta Bionics stock By Investing.com - Investing.com Australia
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Es liegen keine Finanzdaten für Beta Bionics Inc (BBNX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):